Investors Grab KYTX 12.3% Cheaper Than Its Secondary Stock Offering

Looking back to 2 days ago, Kyverna Therapeutics Inc (KYTX) priced a 13,333,333 share secondary stock offering at $7.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time. In trading on Friday, bargain hunters could buy shares of KYTX and achieve a cost basis 12.3% cheaper than those buyers, with shares changing hands as low as $6.58 per share.

Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. At last check, Kyverna Therapeutics Inc shares are currently trading up about 1.3% on the day. The chart below shows the one year performance of KYTX shares, versus its 200 day moving average:

Looking at the chart above, KYTX's low point in its 52 week range is $1.78 per share, with $13.67 as the 52 week high point — that compares with a last trade of $7.21.

---

Special Offer: Join the income investing conversation on ValueForum.com with a special Seven Days for Seven Dollars invitation.